Beryl Drugs Limited (BOM:524606)

Market Cap	93.32M -28.6%
Revenue (ttm)	176.65M -12.3%
Net Income	141.00K -82.3%
EPS	0.03 -83.1%
Shares Out	5.07M
PE Ratio	661.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,906
Average Volume	9,266
Open	19.89
Previous Close	20.30
Day's Range	18.01 - 19.89
52-Week Range	15.92 - 30.00
Beta	-0.08
RSI	41.18
Earnings Date	May 29, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In fiscal year 2025, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.69%.